Tripeptide-29
The minimal collagen-mimetic tripeptide (Gly-Pro-Hyp) that stimulates fibroblast collagen synthesis and resists photoaging.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Suggested dose
1,000 – 2,500 mg/day
Compound profile
Scientific & efficacy data
Cosmetic
Peptide profile
Limited human trials
Tripeptide-29
1,000-2,500 mg/day of Gly-Pro-Hyp-rich collagen tripeptide · Once daily
Molecular formula
C12H19N3O5
- Mol. weight
- 285.3 Da
- CAS number
- 2239-67-0
- PubChem
- Not individually indexed (collagen-derived tripeptide)
- Developed · 2007
- Collaborative research (cosmetic peptide development)
Multiple cosmetic research companies and universities
Amino acid sequence
Gly-Pro-Hyp (glycyl-prolyl-4-hydroxyproline) — the fundamental collagen triple helix repeat unitCollagen Synthesis
The fundamental Gly-Pro-Hyp repeat of collagen activates p38 MAPK signaling in fibroblasts, upregulating collagen I/III expression while suppressing MMP-mediated degradation.
Anti-Photoaging
Demonstrated potent anti-photoaging activity in UV-exposed skin models, reducing wrinkle depth, improving epidermal thickness, and modulating IL-17/TNF inflammatory pathways.
Skin Hydration
Clinical trials show significant improvement in skin hydration by 6 weeks through both direct hyaluronic acid synthesis stimulation and reduced transepidermal water loss.
Dosing
How much do I take?
1,000 – 2,500 mg/day · once daily · oral
1,000 – 2,500 mg/day
Once daily
Covers all 2 documented dose levels · 2 administration routes · timing · dose-adjustment guidance.
Suitability
Is this right for me?
Best for individuals seeking evidence-based collagen supplementation for skin health & those with photoaged skin from chronic sun exposure
Best for
Individuals seeking evidence-based collagen supplementation for skin health
Tripeptide-29 is particularly well-suited for individuals focused on individuals seeking evidence-based collagen supplementation for skin health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with photoaged skin from chronic sun exposure
Tripeptide-29 is particularly well-suited for individuals focused on those with photoaged skin from chronic sun exposure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People wanting to support skin hydration and elasticity from both oral and topical routes
Tripeptide-29 is particularly well-suited for individuals focused on people wanting to support skin hydration and elasticity from both oral and topical routes. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Users looking for a collagen-mimetic peptide with clinical trial data supporting efficacy
Tripeptide-29 is particularly well-suited for individuals focused on users looking for a collagen-mimetic peptide with clinical trial data supporting efficacy. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Tripeptide-29 with similar peptides to find the best fit for your goals.
Administration
How do I use it?
Topical · Oral
Route
Tripeptide-29 is administered Topical—no injection required
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is it safe?
4 common side effects · 2 serious
Tripeptide-29 (Gly-Pro-Hyp, glycyl-prolyl-hydroxyproline) is a naturally occurring collagen-derived tripeptide with an excellent cosmetic safety profile.
This is the fundamental repeat unit of collagen protein, making it highly biocompatible. Both oral and topical forms demonstrate minimal adverse effects in clinical trials. No serious adverse events have been reported in published clinical studies spanning over 15 years.
The tripeptide is generally recognized as safe (GRAS) for both topical and oral use by regulatory authorities. Individual responses are generally benign and limited to mild gastrointestinal adjustment with oral supplementation or transient dermal warmth with topical application.
The primary safety consideration is allergenicity in individuals with gelatin or collagen allergies, which is rare but requires awareness. Molecular weight (285.3 Da) ensures limited systemic absorption when applied topically.
Tripeptide-29 is supported by multiple randomized, double-blind, placebo-controlled clinical trials published in peer-reviewed dermatology journals.
Studies involving 64+ participants demonstrated collagen synthesis improvement and wrinkle reduction at concentrations of 0.5-2% over 12-week treatment periods. Safety data from these trials shows no serious adverse events.
Common side effects · experienced by some users
Mild Gastrointestinal Adjustment
Some individuals experience mild bloating or digestive adjustment during the first few days of oral collagen supplementation.
Management: Take with food. Start with lower dose and increase gradually. Symptoms typically resolve within 3-5 days.
Aftertaste (oral)
Marine-sourced collagen peptides may have a slight fishy aftertaste in some formulations.
Management: Mix with flavored beverages, smoothies, or use flavored collagen products. Bovine-sourced peptides have milder taste.
Mild Skin Warmth (topical)
Slight warming sensation upon topical application, particularly at higher concentrations. Generally benign.
Management: Normal response to active ingredient. If uncomfortable, reduce concentration or frequency of application.
Initial Skin Purging
Rare minor breakout during the first 1-2 weeks of topical use as skin cell turnover increases.
Management: Continue use unless irritation is significant. Skin typically clears within 2 weeks. Reduce frequency if needed.
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Tripeptide-29
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Tripeptide-29 should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- Safe:Vitamin C (stabilized forms) — May be used together under medical guidance.
- Safe:Hyaluronic Acid — May be used together under medical guidance.
- Safe:Niacinamide — May be used together under medical guidance.
With medications
- Caution:Strong oxidizing agents — Use with caution—discuss with your healthcare provider.
- Caution:Highly acidic products (pH <3) — Use with caution—discuss with your healthcare provider.
- Caution:Strong alkaline products (pH >8) — Use with caution—discuss with your healthcare provider.
With supplements
- Safe:Multivitamins — Generally safe to take alongside Tripeptide-29. Space doses apart if taking oral formulations to ensure optimal absorption.
- Safe:Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
How do I know it's working?
Limited human trials · first signs weeks 2-6
Evidence level
Limited human trials
Regulatory status
Research compound
Onset of effects
Moderate
(1-2 weeks)
How it works
Tripeptide-29 is a short three-amino-acid peptide that stimulates collagen synthesis and improves skin firmness.
It works by signaling fibroblast cells to produce more of the structural proteins that keep skin tight and elastic, helping reduce sagging and improve skin texture.
The deeper mechanism
Tripeptide-29 is a three-amino-acid signal peptide sequence designed to stimulate fibroblast-mediated collagen synthesis through growth factor receptor mimicry.
The tripeptide sequence activates TGF-β responsive elements and MAP kinase pathways in fibroblasts, increasing type I and III collagen gene expression and protein synthesis.
Unlike lipidated variants, the hydrophilic tripeptide requires formulation with penetration enhancers for adequate dermal delivery.
Tripeptide-29 increases dermal ECM density, improves skin mechanical properties (firmness, elasticity), and promotes tissue remodeling through controlled MMP activation. Clinical studies document improved skin texture and reduced fine lines with 4-8 weeks of twice-daily topical application.
What to expect
Weeks 2-6
What you might notice
- Early adaptation phase
- Oral: Gly-Pro-Hyp and Pro-Hyp metabolites accumulate in skin tissue
- Topical: fibroblast signaling activation begins
- Measurable improvement in skin hydration observed by week 6 in clinical trials
What's normal
- The adaptation phase to Tripeptide-29 is progressing
- Tripeptide-29 response varies based on individual metabolism and genetics
- Any residual adjustment effects from Tripeptide-29 should resolve soon
What's next
- Maintain Tripeptide-29 dosing exactly as established
- Track progress toward intended outcomes in detail
- Review lab work or biomarker changes with your healthcare team
Weeks 6-8
What you might notice
- Significant improvement threshold
- Wrinkle reduction becomes measurable
- Elasticity parameters improve
- Skin moisture and texture enhancement clearly visible
What's normal
- Tripeptide-29 has achieved stable, long-term homeostatic integration
- Sustained efficacy of Tripeptide-29 remains consistent
- Chronic Tripeptide-29 effects remain stable and predictable
What's next
- Maintain your established Tripeptide-29 protocol for sustained benefits
- Continue periodic monitoring to confirm Tripeptide-29 efficacy
- Review comprehensive Tripeptide-29 response with your provider
Weeks 8-12+
What you might notice
- Optimal results window
- Maximum elasticity and wrinkle depth improvements documented in RCTs
- Sustained collagen synthesis benefits compound with continued use
- Benefits persist 2+ weeks after discontinuation
What's normal
- Full therapeutic effects of Tripeptide-29 are well-characterized at this point
- Maintenance of Tripeptide-29's therapeutic effects is typical
- Tolerance patterns with Tripeptide-29 are generally stable over months
What's next
- Comprehensive assessment of Tripeptide-29 efficacy should be conducted
- Discuss long-term continuation, cycling, or protocol modifications
- Continue regular monitoring of relevant biomarkers or symptoms
Signs it's working
Treatment Response
- Improvement in the primary symptoms or condition being treated
- Positive changes in relevant lab values or clinical markers
- Consistent, stable response to Tripeptide-29 over time
- Reduction in symptom frequency or severity
General Well-being
- Improved energy levels and daily functioning
- Better quality of life related to the treated condition
- Manageable or absent side effects indicating good tolerance
- Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- Insufficient time at target dose—most compounds need several weeks to show full benefits
- Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- Individual variation in response—genetics, metabolism, and other factors affect outcomes
- Underlying conditions or medications interfering with absorption or effectiveness
- Improper storage leading to degraded product—always verify proper storage conditions
Key research
Questions
Frequently asked
Is oral or topical Tripeptide-29 more effective?
Both routes have clinical evidence. Oral supplementation has stronger RCT data (multiple double-blind studies) and achieves systemic skin benefits. Topical application provides localized benefits with direct fibroblast stimulation. Combining both oral and topical delivers the most comprehensive results.
How does Tripeptide-29 differ from regular collagen supplements?
Tripeptide-29 (Gly-Pro-Hyp) is the specific bioactive unit within collagen that drives skin benefits. Standard collagen supplements contain a mixture of peptides of various sizes. Products enriched in Gly-Pro-Hyp tripeptide content (>3-11%) show stronger clinical results because they deliver more of the active signaling molecule.
Can vegans use Tripeptide-29?
Traditional Tripeptide-29 is derived from animal collagen (bovine, porcine, or marine). Synthetic versions of the Gly-Pro-Hyp sequence exist but are less common in commercial products. Vegans should look for synthetic or recombinant collagen peptide sources, though these are currently limited in availability.
Does Tripeptide-29 help with UV-damaged skin?
Yes. Research shows Gly-Pro-Hyp has potent anti-photoaging activity, reducing UV-induced MMP expression, improving epidermal thickness, and modulating inflammatory IL-17 and TNF signaling pathways. It helps repair and prevent further UV-mediated collagen degradation.
How long do results last after stopping supplementation?
Clinical data suggests benefits persist for at least 2 weeks after discontinuation, as the newly synthesized collagen remains in the dermal matrix. However, the ongoing stimulatory effect requires continued supplementation. Long-term use provides the best sustained results.
Further reading
History & related research
History · since 1995
The collagen fragment that tells your skin to repair and rebuild itself
Tripeptide-29 is a tiny piece of collagen, the main protein that holds your skin together. Collagen is like the scaffolding that holds a building up.
Read the full history of Tripeptide-29Ready for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for Tripeptide-29, on one page.